Product Details for ANDA 075672
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE)
2.5MG;6.25MG
Marketing Status: Discontinued
5MG;6.25MG
Marketing Status: Discontinued
10MG;6.25MG
Marketing Status: Discontinued
2.5MG;6.25MG
Marketing Status: Discontinued
Active Ingredient: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075672
Product Number: 001
Approval Date: Sep 25, 2000
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE)
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075672
Product Number: 001
Approval Date: Sep 25, 2000
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG;6.25MG
Marketing Status: Discontinued
Active Ingredient: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075672
Product Number: 002
Approval Date: Sep 25, 2000
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE)
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075672
Product Number: 002
Approval Date: Sep 25, 2000
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG;6.25MG
Marketing Status: Discontinued
Active Ingredient: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075672
Product Number: 003
Approval Date: Sep 25, 2000
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG;6.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075672
Product Number: 003
Approval Date: Sep 25, 2000
Applicant Holder Full Name: ACTAVIS ELIZABETH LLC
Marketing Status: Discontinued
Patent and Exclusivity Information